FDA Approved: PERTZYE — Supplemental Application (Digestive Care, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for PERTZYE (pancrelipase) from Digestive Care, Inc., updating its labeling under the supplemental submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Exocrine Pancreatic Insufficiency
• Pancreatitis

Drugs mentioned

• PERTZYE (PANCRELIPASE)

Snippet

SUPPL AP for PERTZYE (PANCRELIPASE)